SEARCH

SEARCH BY CITATION

References

  • 1
    Harvey CE, OBrien JA, Felsburg PJ, et al. Nasal penicilliosis in six dogs. J Am Vet Med Assoc 1981; 178:10841087.
  • 2
    Sharp NJH. Canine nasal aspergillosis/peniciIliosis. In: Greene, CE, ed. Clinical Microbiology and Infectious Diseases of the Dog and Cat. Philadelphia : WB Saunders, 1990; 714718.
  • 3
    Harvey CE, OBrien JA. Nasal aspergillosis-penicilliosis. In: KirkRW, ed. Current Veterinary Therapy, VIII, Philadelphia : WB Saunders, 1983; 236241.
  • 4
    Sharp NJH, Burrell MH, Sullivan M., et al. Canine nasal aspergillosis: serology and treatment with ketoconazole. J Small Anim Pract 1984; 25:149158.
  • 5
    Harvey CE. Nasal aspergillosis and penicilliosis in dogs: results of treatment with thiabendazole. J Am Vet Med Assoc 1984; 184:4850.
  • 6
    Sharp NJH, Sullivan M. Use of ketoconazole treatment of canine nasal aspergillosis. J Am Vet Med Assoc 1989; 194:782786.
  • 7
    Desplenter L. New possibilities in the treatment of dermatomycoses and ofAspergillus fumigatus. vanMientAS, FrensJ., van derKreekFW, eds. Proc 1st Eur Cong Vet Pharmacol Toxicol, Zeist, The Netherlands, Amsterdam : Elsevier Scientific Publishing Co., 1979; 266274.
  • 8
    Sharp NJH, Sullivan M. Treatment of canine nasal aspergillosis with systemic ketoconazole and topical enilconazole. Vet Rec 1986; 118:560561.
  • 9
    Murray JL, Mahgoub ES. Further studies on the diagnosis of mycetoma by double diffusion in agar. Sabouraudia 1968; 6: 10612.
  • 10
    Sharp NJH. Nasal aspergillosis. In: KirkRW, ed. Current Veterinary Therapy. Philadelphia : WB Saunders, 1989; 11061109.
  • 11
    Sharp NJH, Sullivan M., Harvey CE. Treatment of canine nasal aspergillosis. In Practice, 1992; 14: 2731.
  • 12
    Dismukes WE, Bennett JE, Drutz OJ, et al. Criteria for evaluation of therapeutic response to antifungal drugs. Rev Infect Dis 1980; 2:535545.
  • 13
    Sullivan M., Lee R., Jakovljevic J., et al. The radiological features of aspergillosis of the nasal cavity and frontal sinuses in the dog. J Small Anim Pract 1986; 27: 167180.
  • 14
    Thienpont D., Van Cutsem J., Van Cauteren H., et al. The biological and toxicological properties of imazalil. Drug Res 1981; 311:30915.
  • 15
    Siegel MR, Ragsdale NN. Antifungal mode of action of imazalil. Pest Biochem Physiol 1978; 9:4856.
  • 16
    Van Tuyl JM. Genetic aspects of resistance to imazalil in Aspergillus nidulans. Neth J Plant Pathol 1977; 83:169.
  • 17
    Van Gestel J., Van Cutsem J., Thienpont D. Vapor phase activity of imazalil. Chemotherapy 1981; 27:270276.
  • 18
    Sharp NJH, Harvey CE, OBrien JA. Treatment of canine nasal aspergillosis/penicilliosis with fluconazole (UK-49.858). J Small Anim Pract 1991; 32513516.
  • 19
    Sharp NJH, Harvey CE, Sullivan M. Canine nasal aspergillosis and penicilliosis. Comp Cont Educ Pract Vet 1991; 13:4149.